Valbiotis
Develops clinically tested, plant-based supplements for metabolic & cardiovascular health.
ALVAL | PA
Overview
Corporate Details
- ISIN(s):
- FR0013254851
- LEI:
- 969500VP4JBJCF0MOP60
- Country:
- France
- Address:
- RUE PAUL VATINE, 17180 PERIGNY
- Website:
- https://www.valbiotis.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Valbiotis is a research and development company committed to scientific innovation for the prevention and management of metabolic and cardiovascular diseases. The company specializes in developing and marketing plant-based, clinically tested dietary supplements and active substances. Its core focus is on major health risk factors including prediabetes, dyslipidemia, arterial hypertension, and metabolic liver diseases. Leveraging its botanical expertise, Valbiotis creates multi-target active substances that act on multiple physiological pathways. The company's product portfolio, including the ValbiotisPRO® range, is distributed through pharmacies and is aimed at both healthcare professionals and consumers seeking scientifically validated natural health solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-13 17:45 |
Declaration of Voting Results & Voting Rights Announcements
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote …
|
French | 150.8 KB | ||
| 2025-10-13 17:45 |
Declaration of Voting Results & Voting Rights Announcements
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote …
|
French | 18.2 KB | ||
| 2025-10-09 17:45 |
Earnings Release
VALBIOTIS SA: Valbiotis publishes its interim financial statements and confirms…
|
English | 298.7 KB | ||
| 2025-10-09 17:45 |
ISS
VALBIOTIS SA: Valbiotis publie ses comptes semestriels et confirme sa feuille d…
|
French | 306.2 KB | ||
| 2025-10-09 17:45 |
Earnings Release
VALBIOTIS SA: Valbiotis publishes its interim financial statements and confirms…
|
English | 43.8 KB | ||
| 2025-09-01 11:40 |
Declaration of Voting Results & Voting Rights Announcements
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote …
|
French | 18.2 KB | ||
| 2025-08-11 17:30 |
Declaration of Voting Results & Voting Rights Announcements
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote …
|
French | 18.2 KB | ||
| 2025-07-03 17:45 |
Declaration of Voting Results & Voting Rights Announcements
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote …
|
French | 165.4 KB | ||
| 2025-07-03 17:45 |
Regulatory News Service
VALBIOTIS SA: Bilan semestriel du contrat de liquidité
|
French | 359.3 KB | ||
| 2025-07-03 17:45 |
Declaration of Voting Results & Voting Rights Announcements
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote …
|
French | 19.3 KB | ||
| 2025-06-26 17:40 |
Share Issue/Capital Change
VALBIOTIS SA: Valbiotis announces the success of its €6.9 million rights issue …
|
English | 470.3 KB | ||
| 2025-06-26 17:40 |
Share Issue/Capital Change
VALBIOTIS SA: Valbiotis annonce le succès de son augmentation de capital de 6,9…
|
French | 419.2 KB | ||
| 2025-06-26 17:40 |
Share Issue/Capital Change
VALBIOTIS SA: Valbiotis announces the success of its 6.9 million rights issue e…
|
English | 142.5 KB | ||
| 2025-06-06 08:00 |
Share Issue/Capital Change
VALBIOTIS SA: Valbiotis announces the launch of a capital increase with maintai…
|
English | 579.9 KB | ||
| 2025-06-06 08:00 |
Share Issue/Capital Change
VALBIOTIS SA: Valbiotis annonce le lancement d’une augmentation de capital avec…
|
French | 511.1 KB |
Automate Your Workflow. Get a real-time feed of all Valbiotis filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Valbiotis via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-01-17 | N/A | Other | Other | 10,400 | 46,072.00 EUR |
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
